Type III Interferon as an Effective Therapy for COVID-19 Infection
| dc.contributor.advisor | Nancy J. Bigley, Ph. D. Thesis Director | |
| dc.contributor.author | ALANOUD GHASSAN GHONAIM | |
| dc.date | 2021 | |
| dc.date.accessioned | 2022-06-01T11:10:45Z | |
| dc.date.available | 2022-06-01T11:10:45Z | |
| dc.degree.department | Microbiology and Immunology | |
| dc.degree.grantor | Wright state university | |
| dc.description.abstract | the hypothesis of the study is that innate immunity interferons (type I and III IFNs) are beneficial therapeutics for SARS-CoV-2 infection, and type III IFNs maybe are more effective than type I IFNs, especially in the early stage of infection of covid-19. | |
| dc.identifier.uri | https://drepo.sdl.edu.sa/handle/20.500.14154/57447 | |
| dc.language.iso | en | |
| dc.title | Type III Interferon as an Effective Therapy for COVID-19 Infection | |
| sdl.thesis.level | Master | |
| sdl.thesis.source | SACM - United States of America |